ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation

FRA:ABLUS0028241000

Current stock price

78.12 EUR
+0.06 (+0.08%)
Last:

This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ABL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ABL was profitable.
  • ABL had a positive operating cash flow in the past year.
  • In the past 5 years ABL has always been profitable.
  • Each year in the past 5 years ABL had a positive operating cash flow.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • ABL has a better Return On Assets (7.52%) than 85.25% of its industry peers.
  • ABL's Return On Equity of 12.51% is amongst the best of the industry. ABL outperforms 80.33% of its industry peers.
  • ABL has a Return On Invested Capital of 9.14%. This is in the better half of the industry: ABL outperforms 75.41% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ABL is in line with the industry average of 10.31%.
  • The last Return On Invested Capital (9.14%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.14%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ABL has a Profit Margin of 14.72%. This is amongst the best in the industry. ABL outperforms 88.52% of its industry peers.
  • ABL's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ABL (18.78%) is better than 77.05% of its industry peers.
  • ABL's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ABL (56.66%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
Industry RankSector Rank
OM 18.78%
PM (TTM) 14.72%
GM 56.66%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

7

2. ABL.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABL is creating some value.
  • The number of shares outstanding for ABL has been increased compared to 1 year ago.
  • Compared to 5 years ago, ABL has less shares outstanding
  • Compared to 1 year ago, ABL has an improved debt to assets ratio.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • ABL has an Altman-Z score of 4.52. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
  • ABL has a better Altman-Z score (4.52) than 77.05% of its industry peers.
  • The Debt to FCF ratio of ABL is 1.75, which is an excellent value as it means it would take ABL, only 1.75 years of fcf income to pay off all of its debts.
  • ABL has a Debt to FCF ratio of 1.75. This is in the better half of the industry: ABL outperforms 78.69% of its industry peers.
  • ABL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • ABL's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. ABL outperforms 68.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 4.52
ROIC/WACC1.09
WACC8.42%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.58, ABL perfoms like the industry average, outperforming 47.54% of the companies in the same industry.
  • A Quick Ratio of 1.18 indicates that ABL should not have too much problems paying its short term obligations.
  • ABL has a Quick ratio (1.18) which is comparable to the rest of the industry.
  • ABL does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

5

3. ABL.DE Growth Analysis

3.1 Past

  • ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.00%, which is quite good.
  • The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
  • Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 6.59% in the last year.
  • The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
  • ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y7.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

5

4. ABL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.52 indicates a rather expensive valuation of ABL.
  • Based on the Price/Earnings ratio, ABL is valued cheaply inside the industry as 85.25% of the companies are valued more expensively.
  • ABL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.42.
  • ABL is valuated correctly with a Price/Forward Earnings ratio of 14.54.
  • Based on the Price/Forward Earnings ratio, ABL is valued a bit cheaper than 73.77% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.24. ABL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.52
Fwd PE 14.54
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 68.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.47
EV/EBITDA 14.17
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • ABL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.63
PEG (5Y)2.46
EPS Next 2Y10.46%
EPS Next 3Y10.33%

6

5. ABL.DE Dividend Analysis

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.72%.
  • ABL's Dividend Yield is rather good when compared to the industry average which is at 1.26. ABL pays more dividend than 80.33% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, ABL pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.72%

5.2 History

  • On average, the dividend of ABL grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • ABL pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
  • ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

ABL.DE Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

FRA:ABL (4/24/2026, 7:00:00 PM)

78.12

+0.06 (+0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-16
Earnings (Next)07-15
Inst Owners81.92%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap135.75B
Revenue(TTM)45.13B
Net Income(TTM)6.52B
Analysts80.57
Price Target113.78 (45.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.72%
Yearly Dividend2.03
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)-0.41%
PT rev (3m)-9.11%
EPS NQ rev (1m)-0.43%
EPS NQ rev (3m)-4.74%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-2.14%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 17.52
Fwd PE 14.54
P/S 3.58
P/FCF 21.47
P/OCF 16.59
P/B 3.05
P/tB 7.03
EV/EBITDA 14.17
EPS(TTM)4.46
EY5.71%
EPS(NY)5.37
Fwd EY6.88%
FCF(TTM)3.64
FCFY4.66%
OCF(TTM)4.71
OCFY6.03%
SpS21.81
BVpS25.65
TBVpS11.11
PEG (NY)1.63
PEG (5Y)2.46
Graham Number50.7385 (-35.05%)
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.86%
ROIC 9.14%
ROICexc 10.47%
ROICexgc 20.23%
OM 18.78%
PM (TTM) 14.72%
GM 56.66%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.28
Cash Conversion 83.6%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 4.52
F-Score6
WACC8.42%
ROIC/WACC1.09
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y7.06%
EBIT growth 1Y18.35%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year26.44%
EBIT Next 3Y14.4%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.


How profitable is ABBOTT LABORATORIES (ABL.DE) stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.


What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?

The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 7 / 10.


Is the dividend of ABBOTT LABORATORIES sustainable?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 6 / 10 and the dividend payout ratio is 63.09%.